Physician profile
Jared Menchin
NPI 1316357262
$5,887.73
in general payments reported to CMS, 2019-2025
15 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,397 · 2020: $557 · 2021: $721 · 2022: $2,123 · 2024: $969 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.07 |
| Travel and Lodging | $411.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,863.11 | 2019-2024 | Prostep |
| Arthrex, INC. | $1,244.00 | 2022 | |
| Paragon 28, INC. | $671.50 | 2024 | Monkey Rings |
| Treace Medical Concepts, INC. | $390.78 | 2019-2025 | |
| Medinc of Texas | $304.31 | 2022 | |
| Amgen INC. | $171.17 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $92.61 | 2024 | Footprint, Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix |
| Zimmer Biomet Holdings, INC. | $28.54 | 2020 | |
| Biowound Solutions, INC. | $23.05 | 2025 | Bio-Connekt |
| Mimedx Group, INC. | $21.09 | 2025 | |
| Celularity INC. | $17.87 | 2020 | |
| Medtronic, INC. | $17.77 | 2021 | |
| Bone Support INC. | $14.94 | 2024 | Ceramentbone Void Filler, Cerament G |
| Globus Medical, INC. | $14.21 | 2024 | Allocate |
| Kerecis Limited | $12.78 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Menchin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.